RTI Surgical, Inc. (NASDAQ:RTIX) Cut to “Hold” at BidaskClub

BidaskClub cut shares of RTI Surgical, Inc. (NASDAQ:RTIX) from a buy rating to a hold rating in a research note issued to investors on Tuesday morning.

Other equities analysts also recently issued reports about the stock. Zacks Investment Research upgraded shares of RTI Surgical from a hold rating to a buy rating and set a $6.25 target price on the stock in a report on Wednesday, June 28th. ValuEngine upgraded shares of RTI Surgical from a sell rating to a hold rating in a report on Friday, June 2nd. Finally, TheStreet upgraded shares of RTI Surgical from a d+ rating to a c- rating in a report on Friday, May 5th.

RTI Surgical (RTIX) traded up 1.05% during mid-day trading on Tuesday, reaching $4.80. 288,735 shares of the company traded hands. RTI Surgical has a one year low of $2.50 and a one year high of $6.00. The stock’s 50-day moving average price is $5.57 and its 200-day moving average price is $4.50. The firm’s market cap is $283.36 million.

RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.02. RTI Surgical had a negative net margin of 6.53% and a positive return on equity of 2.07%. The company had revenue of $72.10 million for the quarter, compared to the consensus estimate of $70.25 million. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. Analysts forecast that RTI Surgical will post $0.07 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Stock Observer and is owned by of Stock Observer. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://www.thestockobserver.com/2017/08/12/rti-surgical-inc-nasdaqrtix-cut-to-hold-at-bidaskclub.html.

In other news, CEO Camille Farhat bought 61,693 shares of the stock in a transaction that occurred on Thursday, May 18th. The shares were acquired at an average cost of $4.65 per share, for a total transaction of $286,872.45. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 4.90% of the stock is currently owned by insiders.

Institutional investors have recently modified their holdings of the company. Victory Capital Management Inc. increased its position in shares of RTI Surgical by 1.1% in the second quarter. Victory Capital Management Inc. now owns 220,569 shares of the medical equipment provider’s stock worth $1,290,000 after buying an additional 2,295 shares during the last quarter. American International Group Inc. increased its position in shares of RTI Surgical by 7.0% in the first quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock worth $141,000 after buying an additional 2,327 shares during the last quarter. Bank of America Corp DE increased its position in shares of RTI Surgical by 6.4% in the first quarter. Bank of America Corp DE now owns 39,786 shares of the medical equipment provider’s stock worth $159,000 after buying an additional 2,389 shares during the last quarter. Gagnon Securities LLC increased its position in shares of RTI Surgical by 1.7% in the first quarter. Gagnon Securities LLC now owns 266,004 shares of the medical equipment provider’s stock worth $1,064,000 after buying an additional 4,466 shares during the last quarter. Finally, Federated Investors Inc. PA increased its position in shares of RTI Surgical by 16.3% in the second quarter. Federated Investors Inc. PA now owns 43,245 shares of the medical equipment provider’s stock worth $253,000 after buying an additional 6,065 shares during the last quarter. Institutional investors and hedge funds own 68.53% of the company’s stock.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply